98 CHAPTER 4 a: phosphosites upregulated in primary resistant patients (continued) Phosphosite p-value FC NCS1_Y97 0.022 9.4 DOK3_Y342 0.023 6.3 CLDN1_Y210 0.025 6.0 STAT4_Y693 0.029 4.2 PRMT1_Y263 0.030 3.3 NPHP3_Y467 0.031 10.5 ALOX5_Y95 0.033 5.3 PKP2_Y10 0.034 11.0 SERINC5_Y345 0.038 9.8 ACTN4_Y265 0.045 4.4 SAMHD1_Y315 0.047 3.9 b: phosphosites upregulated in sensitive patients Phosphosite p-value FC Uniquely identified in sensitive tumors PEAK1_Y635 n/a n/a EPHA2_Y575 n/a n/a NCK2_Y110 n/a n/a TLN1_Y26 n/a n/a EGFR_Y1138 n/a n/a CTNND1_Y174 n/a n/a CDK2_S90 n/a n/a NSFL1C_Y167 n/a n/a FLNA_Y346 n/a n/a MTMR10_Y708 n/a n/a AKR1A1_Y50 n/a n/a BCAR1_Y304 n/a n/a GRASP_Y94 n/a n/a TUBA1B_Y357 n/a n/a TNS2_Y581 n/a n/a ARAP1_Y747 n/a n/a SHANK2_Y321 n/a n/a GSTA1_Y132 n/a n/a PYGL_Y170 n/a n/a NIPSNAP1_Y148 n/a n/a SDHA_Y523 n/a n/a FBP2_Y216 n/a n/a
RkJQdWJsaXNoZXIy MTk4NDMw